SCD and Mediterranean Diets Shown to Ease Crohn’s Symptoms

At the 2021 Crohn’s and Colitis Congress, a randomized clinical trial was presented by the University of Pennsylvania. This trial showed remission of Crohn’s by following the Specific Carbohydrate Diet or the Mediterranean diet. In fact, 47% and 44% percent achieved remission after six weeks respectively. Not only were inflammation levels lowered, checked by C-reactive … Read more

New Wireless Capsule Technology for Treatment of IBD

At the Crohn’s & Colitis Congress in January a new revolutionary medication delivery system was unveiled by SmartTab. They are working towards a wireless ‘smart’ pill that will release at exact points in the gut where you need the medicine the most. This exciting innovation could replace biologics as we know them. It would eliminate … Read more

KCNN4 Potassium Channel: Novel Biomarker, and Possible Therapeutic Option for IBD

Researchers in Germany have found a potential novel biomarker for those who have IBD. With experimentation, they believe it may pave the way for a new possible therapeutic option for those with Crohn’s and Colitis. The KCNN4 channel is known to be involved in inflammatory diseases, and is responsible for epithelial ion transport and intestinal … Read more

New Phage Therapy BX003 in the Pipelines as Possible IBD Treatment

BiomX has created a new phage oral therapy that targets specific bacteria, thought to exacerbate symptoms, in the gut of IBD patients. This new possible treatment is in the pipelines, but has shown promising results in its Phase 1 human trials. This new therapy, called BX003, works by using bacteriophages (phages)which are viruses that infect … Read more